Zosano Pharma Corp. | Mutual Funds
Mutual Funds that own Zosano Pharma Corp.
Vanguard Total Stock Market Index Fund
354,246
2.96%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
160,759
1.34%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
53,023
0.44%
0
0%
07/31/2018
LO Funds - Fundamental Equity Long/Short Syst. Hdg. Seed.
35,865
0.3%
1,959
0.03%
09/30/2017
iShares Micro Cap ETF
25,415
0.21%
0
0.01%
09/06/2018
Fidelity Spartan Total Market Index Fund
22,328
0.19%
0
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
20,058
0.17%
0
0%
07/31/2018
Vanguard Balanced Index Fund
17,686
0.15%
0
0%
07/31/2018
Gabelli Equity Trust
16,297
0.14%
16,297
0%
06/30/2018
Vanguard Total Stock Market Index Trust
3,091
0.03%
0
0%
07/31/2018
| Address |
34790 Ardentech Court
Fremont California 94555
United States
|
|
Employees
|
- |
| Website |
http://www.zosanopharma.com |
| Updated |
07/08/2019 |
| Zosano Pharma Corp. operates as a clinical stage pharmaceutical company that develops proprietary intracutaneous delivery system. It offers rapid absorption of drug, consistent drug delivery, improved ease of use and room-temperature stability, benefits that differentiate its delivery platform from other non-oral formulations or injections. The company was founded in January 2012 and is headquartered in Fremont, CA. |
